PRIMARY MEMBRANOUS NEPHROPATHY
Clinical trials for PRIMARY MEMBRANOUS NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MEMBRANOUS NEPHROPATHY trials appear
Sign up with your email to follow new studies for PRIMARY MEMBRANOUS NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a smarter antibody outsmart a kidney disease that resists standard treatment?
Disease control CompletedThis trial tests whether obinutuzumab, a next-generation antibody, can help people with membranous nephropathy—a kidney disease that causes protein leakage and swelling—who haven't responded well to the standard drug rituximab or who can't take it due to allergic reactions. About…
Matched conditions: PRIMARY MEMBRANOUS NEPHROPATHY
Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a pill calm the immune attack on kidneys?
Disease control CompletedThis trial tests an experimental oral drug called EVER001 in people with primary membranous nephropathy, a kidney disease where the immune system damages the kidney's filtering units, causing protein to leak into urine. The study aims to see if EVER001 can reduce proteinuria and …
Matched conditions: PRIMARY MEMBRANOUS NEPHROPATHY
Phase: PHASE1 • Sponsor: Everest Medicines (China) Co.,Ltd. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New antibody drug shows promise for tough kidney disease
Disease control CompletedThis study tested a new drug, MIL62, in 94 adults with primary membranous nephropathy, a serious kidney condition. The goal was to see if MIL62 is safe and can help reduce protein in the urine better than the standard drug cyclosporine. Participants received either MIL62 or cyclo…
Matched conditions: PRIMARY MEMBRANOUS NEPHROPATHY
Phase: PHASE1, PHASE2 • Sponsor: Beijing Mabworks Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Blood cell study may unlock kidney disease secrets
Knowledge-focused CompletedThis study looked at immune cells (T and B cells) in the blood of 44 people with a kidney disease called membranous nephropathy. Researchers wanted to see how these cells relate to treatment response and disease relapse. They also measured specific antibodies linked to the diseas…
Matched conditions: PRIMARY MEMBRANOUS NEPHROPATHY
Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC